TFC Financial Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120 | Buy |
+7
| New | +$120 | ﹤0.01% | 853 |
|
|
2025
Q1 | – | Sell |
-1
| Closed | -$122 | – | 1041 |
|
|
2024
Q4 | $122 | Hold |
1
| – | – | ﹤0.01% | 801 |
|
|
2024
Q3 | $125 | Hold |
1
| – | – | ﹤0.01% | 812 |
|
|
2024
Q2 | $158 | Buy |
+1
| New | +$158 | ﹤0.01% | 748 |
|
|
2023
Q4 | – | Sell |
-67
| Closed | -$8.12K | – | 725 |
|
|
2023
Q3 | $8.12K | Buy |
+67
| New | +$8.12K | ﹤0.01% | 360 |
|
|
2023
Q2 | – | Sell |
-2
| Closed | -$276 | – | 743 |
|
|
2023
Q1 | $276 | Buy |
+2
| New | +$276 | ﹤0.01% | 602 |
|
|
2022
Q1 | – | Sell |
-57
| Closed | -$5K | – | 580 |
|
|
2021
Q4 | $5K | Buy |
+57
| New | +$5K | ﹤0.01% | 397 |
|
|
2020
Q4 | – | Sell |
-15
| Closed | -$2K | – | 594 |
|
|
2020
Q3 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 418 |
|